Location: Home > Pharma China Web Edition
  • search
  • go
  • Regulatory News
  • 9/12/2023China Adjusts the Catalog of Narcotic and Psychotropic Drugs
  • 9/7/2023CDE Releases the Annual Report on New Drug Registration Clinical Trial...
  • 9/6/2023NMPA Solicits Comments on the Guidelines for the Inspection of Third-P...
  • 9/5/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q9(R1)
  • 9/5/2023NMPA Issues the Announcement for Applicability of ICH Guidelines S12
  • 9/4/2023CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 9/1/2023CDE Solicits Comments on the Technical Guidelines for Post-Marketing P...
  • 8/31/2023NMPA and Chinese Customs Announce Addition of Taizhou as a Drug Import...
  • 8/30/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (73...
  • 8/29/2023NMPA Set to Raise the Bar for Conditional Approval Process of New Drug...
  • 8/29/2023NMPA Announces OTC Switch of Paracetamol Orally Dispersion Tablet
  • 8/29/2023NMPA Announces Package Insert Revision of Two Drug Products
  • 8/28/2023CDE Solicits Second Round Comments on Two Pharmaceutical Change Resear...
  • 8/25/2023NMPA Solicits Comments on the Working Procedures for Evaluation and Ap...
  • 8/25/2023NMPA Issues Announcement for Applicability of ICH Guidelines Q12
  • 8/25/2023CDE Seeks Comments on Draft ICH Guidelines M7(R2)
  • 8/23/2023NMPA Issues the List of Reference Formulations for GQCE Studies (72nd ...
  • 8/22/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Six Generi...
  • 8/17/2023NMPA Revises the Information Standard System for Drug Regulatory Digit...
  • 8/17/2023NMPA Issues the List of Reference Formulations for GQCE Studies (71st ...
  • 8/17/2023NMPA Announces Package Insert Revision of Three Drug Products
  • 8/15/2023NHC Releases Q&A Document to Highlight/Clarify Focused Areas of Health...
  • 8/9/2023China Intensifies Efforts to Combat Healthcare Corruption
  • 8/7/2023Crackdown on Chinese Pharma Irregularities Disrupts Medical Conference...
  • 8/7/2023NMPA Holds Meeting to Promote Construction of Drug Regulation Quality ...
  • 8/1/2023CDE Solicits Comments over the Technical Guidelines on Pharmacokinetic...
  • 8/1/2023Review of New Drugs Approved in China H1/2023
  • 7/31/2023CDE Announces Office Relocation and Related Matters
  • 7/28/2023CDE Solicits Comments on Technical Guidance for Clinical Pharmacologic...
  • 7/27/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Five Gener...
  • Page:6/9 Total number of articles:259: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group